Patient support for those prescribedSomatuline Depot.

Once the doctor has prescribed Somatuline® Depot (lanreotide) injection, the Patient Access Specialists at IPSEN CAREScan provide applicable patient coverage information, as appropriate, between the patient, doctor's office, insurance company, and specialty pharmacy. By serving as a central point of contact, IPSEN CARES can help patients get started on treatment and provide support throughout the process.

Step 1
Enroll

Patients must enroll in IPSEN CARES through the doctor's office to verify benefits.

Our Patient Access Specialists will check each patient's pharmacy and medical benefits to determine if the drug is covered for the indication the treating physician has specified. If there are any restrictions, IPSEN CARES will provide the information required by the insurance company that the doctor may need to complete. A summary of all the information collected will be sent back to the doctor’s office in a single document called Benefit Verification Results. Benefit verifications are usually turned around within 4 business hours upon receipt of the completed enrollment form and patient authorization.

Health care providers (HCPs) can help patients enroll in three ways:

  1. Through our online provider portal
  2. By printing a downloadable PDF to be filled out and faxed
  3. By calling the Patient Access Specialists at IPSEN CARESat (866) 435-5677

Patients and Health Care Providers can also call IPSEN CARES at (866) 435-5677

Step 2
Authorize

Patients are required to sign the Somatuline Depot Patient Authorization form every 12 months to give the Patient Access Specialists at IPSEN CARES permission to access the patient’s personal health information in order to help with treatment. The form can be signed and submitted online, or by downloadable PDF, which must be printed, filled out, signed, and faxed.

Patients, Sign and Submit
Online Patient Authorization Form
Or Download and Print
Patient Authorization Form
Step 3
Help with Copays?

Check for copay coverage. Considering that some patients need financial assistance, our copay assistance programs may help eligible* patients with their treatment.

The Somatuline Depot Copay Program for eligible, commercially insured and uninsured patients is available by enrolling in IPSEN CARES. Here is the key information:

  • Patients are responsible for at least the first $5 of every prescription
  • Copay assistance may be provided with up to a maximum annual benefit of $20,000 for the program year
  • For patients utilizing the Pharmacy Benefit, we will provide the virtual pharmacy copay card information directly to the specialty pharmacy being utilized
  • For patients utilizing the Medical Benefit, we will send the virtual debit card information directly to the doctor’s office for payment once an Explanation of Benefits is received and processed

Below are more ways we can provide assistance

Injections at Home

Home Health Administration (HHA) is available for patients who are unable to receive their Somatuline Depot injections at the doctor's office. Eligible patients can have a nurse visit their home to administer their injections. There is no cost to the patient for this option. HHA must be requested by the doctor and the patient must be enrolled in IPSEN CARES.

Free Medication

Uninsured patients may be eligible for free medication through our Patient Assistance Program. To qualify, patients must be: 1) uninsured, 2) US residents, and 3) meet income criteria. Patients may enroll through IPSEN CARES. If eligible, they will receive free medication from Ipsen.

Or Patients, Download and Print
Patient Assistance Program Form
Back to top
*Patient Eligibility & Terms and Conditions: Patients who are eligible to participate (i.e. prescriptions or coverage could be paid in part or in full) in any state or federally funded programs, including, but not limited to, Medicare or Medicaid, VA, DOD, or TRICARE (collectively, “Government Programs”) are not eligible for copay assistance through IPSEN CARES™. Patients residing in Massachusetts, Minnesota, Michigan, or Rhode Island can only receive assistance with the cost of Ipsen products but not the cost of related medical services (injection). Patients receiving free starter therapy through the IPSEN CARES program are not eligible for the copay assistance program while they are waiting for insurance prescription coverage to begin. Patients receiving assistance through another assistance program or foundation, free trial, or other similar offer or program, also are not eligible for the copay assistance program during current enrollment year.For patients with commercial insurance who are not considered to be cash-pay patients, the maximum copay benefit amount per prescription is an amount equal to the difference between the annual maximum copay benefit of $20,000 and the total amount of co-pay benefit provided to the patient in the Somatuline® Depot Copay Program for the 2016 calendar year.  For cash-pay patients, the maximum copay benefit amount per prescription is $1,666.66, subject to the annual maximum of $20,000 in total.  “Cash-pay” patients are defined for purposes of this program as patients without insurance coverage or who have commercial insurance that does not cover Somatuline® Depot.  Medicare Part D enrollees who are in the prescription drug coverage gap (the “donut hole”) are not considered cash-pay patients, and are not eligible for the copay benefit.Patient pays the first $5 and any amount greater than the maximum copay savings amount per prescription.   Patient or guardian is responsible for reporting receipt of copay savings benefit to any insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled through the program, as may be required.  Additionally, patients may not submit any benefit provided by this program for reimbursement through a Flexible Spending Account, Health Savings Account, or Health Reimbursement Account.  Ipsen reserves the right to rescind, revoke, or amend these offers without notice at any time. Ipsen and/or TrialCard, Incorporated, are not responsible for any transactions processed under this program where Medicaid, Medicare, or Medigap payment in part or full has been applied. Cash-paying patients are eligible to participate. Data related to your participation may be collected, analyzed, and shared with Ipsen for market research and other purposes related to assessing the program. Data shared with Ipsen will be de-identified, meaning it will not identify you. Void outside of the United States and its territories or where prohibited by law, taxed, or restricted. This program is not health insurance. No other purchase is necessary. Offer expires December 31, 2017, however, patients residing in Massachusetts are only eligible to receive assistance through June 30, 2017.Patient Eligibility for Home Health Administration: A physician must prescribe Somatuline Depot to be administered by Home Health Administration for the patient. The program is available to most patients covered by commercial insurance plans. Patients are not eligible if prescriptions are paid in part or fully by any state or federally funded programs, including, but not limited to, Medicare or Medicaid, VA, DOD or TRICARE. Residents of Massachusetts, Michigan, Minnesota, and Rhode Island are not eligible.

Indication and Important Safety Information

SHOW MORE
What is SOMATULINE® DEPOT (lanreotide) Injection?

SOMATULINE DEPOT is a prescription medicine used for the treatment of adults for:

  • The long-term treatment of acromegaly when surgery or radiotherapy has not worked well enough or the patient is not able to have surgery or radiotherapy
  • A type of cancer known as neuroendocrine tumors, from the gastrointestinal tract or the pancreas (GEP-NETs) that has spread or cannot be removed by surgery

It is not known if SOMATULINE DEPOT is safe and effective in children.

Important Safety Information

Who should not take SOMATULINE DEPOT?


Do not take SOMATULINE DEPOT if you are allergic to lanreotide.

What are the possible side effects of SOMATULINE DEPOT?

SOMATULINE DEPOT may cause serious side effects, including:

  • Gallstones. Tell your healthcare professional if you get any of these symptoms:
    • sudden pain in your upper right stomach area (abdomen)
    • sudden pain in your right shoulder or between your shoulder blades
    • yellowing of your skin and whites of your eyes
    • fever with chills
    • nausea
  • Changes in your blood sugar (high blood sugar or low blood sugar). If you have diabetes, test your blood sugar as your healthcare professional tells you to. Your healthcare professional may change your dose of diabetes medicine.
  • Slow heart rate
  • High blood pressure

The most common side effects of SOMATULINE DEPOT in people with acromegaly include diarrhea, stomach area (abdominal) pain, nausea, and pain, itching, or a lump at the injection site.

SOMATULINE DEPOT may cause dizziness. If this happens, do not drive a car or operate machinery.

What should I tell my healthcare professional before receiving SOMATULINE DEPOT?
  • Tell your healthcare professional if you have diabetes or gallbladder, thyroid, heart, kidney, or liver problems.
  • Tell your healthcare professional if you are pregnant or plan to become pregnant as SOMATULINE DEPOT may harm your unborn baby. Tell your healthcare professional if you are breastfeeding. It is not known if SOMATULINE DEPOT passes into your breast milk. You and your healthcare professional should decide if you will take SOMATULINE DEPOT or breastfeed. You should not do both.
  • Tell your healthcare professional about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. SOMATULINE DEPOT and other medicines may affect each other, causing side effects. SOMATULINE DEPOT may affect the way other medicines work, and other medicines may affect how SOMATULINE DEPOT works. Especially tell your healthcare professional if you take insulin or other diabetes medicines, a cyclosporine (Gengraf, Neoral, or Sandimmune), a medicine called bromocriptine (Parlodel, Cycloset), or medicines that lower your heart rate, such as beta blockers.

Tell your healthcare professional if you have any side effect that bothers you or that does not go away. These are not all the possible side effects of SOMATULINE DEPOT. For more information ask your healthcare professional.

You are encouraged to report side effects to FDA at 1-800-FDA-1088 or Ipsen Biopharmaceuticals, Inc., at 1-888-980-2889.

See Patient Information for Somatuline Depot

See Full Prescribing Information for Somatuline Depot

Need immediate assistance?Call (866) 435-5677.

Our Patient Access Specialists are available Monday-Friday, from 8:00 AM to 8:00 PM ET (5:00 AM to 5:00 PM PT).

Leaving Website

NOTE: You are about to leave an Ipsen Biopharmaceuticals, Inc. website. This link is provided to you as a service to our website visitors. It will take you to another site maintained by a third party who is solely responsible for its content.

Ipsen Biopharmaceuticals, Inc., does not control or endorse this site. Ipsen is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit. Click “OK” to proceed or “CANCEL” to return to ipsencares.com.

This document is not currently available. Please check back again or contact IPSEN CARES at 1-866-435-5677 (8 AM – 8 PM ET, Monday through Friday).